Concepedia

Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival

Vienna Ludovini, Stefania Gori, Mariantonietta Colozza, Lorenza Pistola, Eliana Rulli, Irene Floriani, E. Pacifico, Francesca Romana Tofanetti, Angelo Sidoni, C. Basurto,

Annals of Oncology · 2008 · 119 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene

Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations

, , +14

Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

S. Eva Singletary, Craig Allred, Pandora Ashley et al. · Journal of Clinical Oncology · 2002 · 1.2K citations

, , +17

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

Hyman B. Muss, Ann D. Thor, Donald A. Berry et al. · New England Journal of Medicine · 1994 · 968 citations · Full text

, , +15

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

B.A. Gusterson, RD Gelber, Aron Goldhirsch et al. · Journal of Clinical Oncology · 1992 · 843 citations

, , +13

Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells.

Jordi Codony‐Servat, Joan Albanell, Federico Rojo et al. · PubMed · 2001 · 775 citations

, , +16